AYTU
Price
$2.04
Change
+$0.05 (+2.51%)
Updated
Oct 14, 10:54 AM (EDT)
Capitalization
23.58M
33 days until earnings call
Intraday BUY SELL Signals
DERM
Price
$5.60
Change
-$0.08 (-1.41%)
Updated
Oct 14, 11:01 AM (EDT)
Capitalization
181.48M
28 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

AYTU vs DERM

AYTU vs DERM Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
AYTU vs. DERM commentary
Oct 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AYTU is a Hold and DERM is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for AYTU with price predictions
Oct 13, 2026

AYTU's Indicator enters downward trend

The Aroon Indicator for AYTU entered a downward trend on September 25, 2026. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 304 similar instances where the Aroon Indicator formed such a pattern. In 271 of the 304 cases the stock moved lower. This puts the odds of a downward move at 89%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 02, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on AYTU as a result. In 87 of 98 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 89%.

The Moving Average Convergence Divergence Histogram (MACD) for AYTU turned negative on October 02, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 51 similar instances when the indicator turned negative. In 44 of the 51 cases the stock turned lower in the days that followed. This puts the odds of success at 86%.

AYTU moved below its 50-day moving average on September 28, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for AYTU crossed bearishly below the 50-day moving average on September 09, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 13 of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 87%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AYTU declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 85%.

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where AYTU's RSI Indicator exited the oversold zone, 34 of 39 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 87%.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 7 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +3.59% 3-day Advance, the price is estimated to grow further. Considering data from situations where AYTU advanced for three days, in 165 of 225 cases, the price rose further within the following month. The odds of a continued upward trend are 73%.

AYTU may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 23 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.668) is normal, around the industry mean (43.873). P/E Ratio (0.005) is within average values for comparable stocks, (141.710). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.152). Dividend Yield (0.000) settles around the average of (0.005) among similar stocks. P/S Ratio (0.320) is also within normal values, averaging (178.797).

The Tickeron PE Growth Rating for this company is 54 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 71 (best 1 - 100 worst), indicating slightly worse than average price growth. AYTU’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AYTU’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock worse than average.

A.I.Advisor
a Summary for DERM with price predictions
Oct 13, 2026

DERM in downward trend: 10-day moving average moved below 50-day moving average on September 28, 2026

The 10-day moving average for DERM crossed bearishly below the 50-day moving average on September 28, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 14 of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 88%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 12, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on DERM as a result. In 79 of 99 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 80%.

The Moving Average Convergence Divergence Histogram (MACD) for DERM turned negative on September 10, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 52 similar instances when the indicator turned negative. In 42 of the 52 cases the stock turned lower in the days that followed. This puts the odds of success at 81%.

DERM moved below its 50-day moving average on September 23, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where DERM declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 84%.

The Aroon Indicator for DERM entered a downward trend on October 13, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where DERM's RSI Indicator exited the oversold zone, 26 of 28 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 90%.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 5 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +6.38% 3-day Advance, the price is estimated to grow further. Considering data from situations where DERM advanced for three days, in 231 of 268 cases, the price rose further within the following month. The odds of a continued upward trend are 86%.

DERM may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 33 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 58 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.650) is normal, around the industry mean (43.873). P/E Ratio (39.077) is within average values for comparable stocks, (141.710). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.152). Dividend Yield (0.000) settles around the average of (0.005) among similar stocks. P/S Ratio (2.865) is also within normal values, averaging (178.797).

The Tickeron Price Growth Rating for this company is 63 (best 1 - 100 worst), indicating fairly steady price growth. DERM’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 96 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. DERM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock worse than average.

FUNDAMENTALS RATINGS
AYTU vs DERM: Fundamental Ratings
AYTU
DERM
OUTLOOK RATING
1..100
9254
VALUATION
overvalued / fair valued / undervalued
1..100
23
Undervalued
58
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9896
PRICE GROWTH RATING
1..100
7163
P/E GROWTH RATING
1..100
5433
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AYTU's Valuation (23) in the Other Consumer Services industry is somewhat better than the same rating for DERM (58) in the Biotechnology industry. This means that AYTU’s stock grew somewhat faster than DERM’s over the last 12 months.

AYTU's Profit vs Risk Rating (100) in the Other Consumer Services industry is in the same range as DERM (100) in the Biotechnology industry. This means that AYTU’s stock grew similarly to DERM’s over the last 12 months.

DERM's SMR Rating (96) in the Biotechnology industry is in the same range as AYTU (98) in the Other Consumer Services industry. This means that DERM’s stock grew similarly to AYTU’s over the last 12 months.

DERM's Price Growth Rating (63) in the Biotechnology industry is in the same range as AYTU (71) in the Other Consumer Services industry. This means that DERM’s stock grew similarly to AYTU’s over the last 12 months.

DERM's P/E Growth Rating (33) in the Biotechnology industry is in the same range as AYTU (54) in the Other Consumer Services industry. This means that DERM’s stock grew similarly to AYTU’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AYTUDERM
RSI
ODDS (%)
Bullish Trend 1 day ago
87%
Bullish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
90%
Momentum
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
80%
MACD
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 3 days ago
81%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
82%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
78%
Bearish Trend 1 day ago
82%
Advances
ODDS (%)
Bullish Trend 21 days ago
73%
Bullish Trend 15 days ago
86%
Declines
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 1 day ago
84%
BollingerBands
ODDS (%)
Bullish Trend 6 days ago
74%
Bullish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
83%
COMPARISON
Comparison
Oct 14, 2026
Stock price -- (AYTU: $1.99 vs. DERM: $5.68)
Brand notoriety: AYTU: Not notable vs. DERM: Notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: AYTU: 66% vs. DERM: 106%
Market capitalization -- AYTU: $23.58M vs. DERM: $181.48M
AYTU [@Pharmaceuticals: Generic] is valued at $23.58M. DERM’s [@Pharmaceuticals: Generic] market capitalization is $181.48M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $2.12K to $68.49B. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $4.13B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AYTU’s FA Score shows that 1 FA rating(s) are green while DERM’s FA Score has 1 green FA rating(s).

  • AYTU’s FA Score: 1 green, 4 red.
  • DERM’s FA Score: 1 green, 4 red.
According to our system of comparison, DERM is a better buy in the long-term than AYTU.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AYTU’s TA Score shows that 4 TA indicator(s) are bullish while DERM’s TA Score has 4 bullish TA indicator(s).

  • AYTU’s TA Score: 4 bullish, 6 bearish.
  • DERM’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, both AYTU and DERM are a bad buy in the short-term.

Price Growth

AYTU (@Pharmaceuticals: Generic) experienced а -2.93% price change this week, while DERM (@Pharmaceuticals: Generic) price change was -7.79% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -3.86%. For the same industry, the average monthly price growth was -3.86%, and the average quarterly price growth was +15.65%.

Reported Earning Dates

AYTU is expected to report earnings on Nov 16, 2026.

DERM is expected to report earnings on Nov 11, 2026.

Industries' Descriptions

@Pharmaceuticals: Generic (-3.86% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

View a ticker or compare two or three
AYTU
Daily Signal:
Gain/Loss:
DERM
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BH388.0522.51
+6.16%
Biglari Holdings
AME250.480.59
+0.24%
Ametek
WAY26.30-0.35
-1.31%
Waystar Holding Corp
USAU13.32-0.58
-4.17%
US Gold Corp
BRLT1.46-0.08
-4.90%
Brilliant Earth Group

AYTU and

Correlation & Price change

A.I.dvisor tells us that AYTU and OGI have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AYTU and OGI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AYTU
1D Price
Change %
AYTU100%
+1.02%
OGI - AYTU
27%
Poorly correlated
-1.68%
ZYBT - AYTU
27%
Poorly correlated
-12.43%
IRWD - AYTU
24%
Poorly correlated
-4.52%
HROW - AYTU
24%
Poorly correlated
-2.99%
DERM - AYTU
23%
Poorly correlated
-3.89%
More

DERM and

Correlation & Price change

A.I.dvisor indicates that over the last year, DERM has been loosely correlated with APUS. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if DERM jumps, then APUS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DERM
1D Price
Change %
DERM100%
-3.89%
APUS - DERM
49%
Loosely correlated
-11.15%
CHRS - DERM
27%
Poorly correlated
+3.88%
CRDL - DERM
23%
Poorly correlated
+1.69%
AMLX - DERM
23%
Poorly correlated
-2.29%
ETON - DERM
23%
Poorly correlated
-3.48%
More